A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells

A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells

The therapeutic effect in non–small cell lung cancer (NSCLC) patients is limited because of intrinsic and acquired resistance. Thus, an unmet need exists for the development of new drugs to improve the therapeutic efficacy in NSCLC patients. In this study, the novel small molecule indolizino[6,7-b]i...

Full description

Bibliographic Details
Main Authors: Chi-Wei Chen, Ming-Hsi Wu, Yi-Fan Chen, Tsai-Yi Yen, Yi-Wen Lin, Shu-Hsin Chao, Satishkumar Tala, Tung-Hu Tsai, Tsann-Long Su, Te-Chang Lee
Format: Article
Language:English
Published: Elsevier 2016-04-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558616000257

Internet

http://www.sciencedirect.com/science/article/pii/S1476558616000257

Similar Items